News
Current position:Product Center > Cell lines > Cytokines > IL-15 > H_IL15 Reporter Cell Line
H_IL15 Reporter Cell Line
Description
Cat. No: GM-C25386
Product: H_IL15 Reporter Cell Line


Interleukin-15 (IL-15) is a pro-inflammatory protein that plays a role in the activation of neutrophils, dendritic cells, and macrophages. It is essential for the development and survival of NK cells and CD8+ T cells.

IL-15 binds to the IL-15Rα receptor and is subsequently presented to surrounding cells with the IL-15Rβγ complex on their surface. It then binds to the IL-15Rβ and IL-15Rγ(common gamma chain, γc) dimer, forming a heterotrimeric receptor complex. IL-15 triggers the phosphorylation of the JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway, after which the phosphorylated STATs dimerize or tetramerize and translocate into the nucleus.

H_IL15 Reporter Cell Line is a clonal, stable cell line that constitutively overexpresses IL-15Rβ and endogenously expresses the γc, along with signal-dependent expression of a luciferase reporter gene. The addition of IL15 ligand protein agonists stimulates IL15 to bind IL-15Rα, IL-15Rβ/γc, activating downstream reporter genes and inducing luciferase expression. This system can be used to evaluate the in vitro effects of drugs related to IL15.
Data
Response to Human IL-15 protein. H_IL15 Reporter Cell Line (Cat. GM-C25386) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-15 Protein (SinoBiological/10360-H07E) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 16 hours. The firefly luciferase activity was measured using the ONE-GloTM Luciferase Assay System (Promega/E6120). The maximum induction fold was approximately [10.3]. Data are shown by drug mass concentration.
The passage stability of response to Human IL-15 protein. The passage 5, 15 and 25 of H_IL15 Reporter Cell Line (Cat. GM-C25386) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-15(SinoBiological/10360-H07E) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Specifications
Cat. NoGM-C25386
ProductH_IL15 Reporter Cell Line
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF
Growth mediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Recombinant Human GM-CSFNovoprotein/C003
PuromycinGenomeditech/GM-040401
BlasticidinGenomeditech/GM-040404
Recombinant Human IL-15Sino Biological/10360-H07E
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
ONE-GloTM Luciferase Assay SystemPromega/E6120
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend the cell pellet using the recommended complete medium and adjust the viable cell density to 4-6E5 cells/mL. Then dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 3E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin

Approximately 48 - 72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics.

a)          This cell is a human erythroid leukemia cell, lymphoblast, growing in suspension.

b)         In the suspension, they appear as large, single, round cells. Cells shed a large accumulation of cytoplasmic granules in the culture, which should not be confused with bacteria!

c)          When the cell density reaches 1-1.2E6 cells/mL, perform a 1:2 to 1:3 split, ensuring subculturing every other day. It is essential to perform a full-volume centrifugation and medium replacement during passaging. Do not let the density exceed 1.2E6 cells/mL. It is recommended to use T-25 flasks for subculturing, and you can control the cell density for subculturing by counting.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 6E5 viable cells/mL.

Medium Renewal: Every other day

Notes

a)          To minimize the presence of cytoplasmic granules, it is essential to passage the cells every other day when the cell density reaches 1-1.2E6 cells/mL. During passaging, perform a complete centrifugation and replace the culture medium to ensure appropriate cell density and cytokine concentration. Failure to do so may promote the growth of factor-independent subclones.

 

Current Position:Product Center > Cell lines > Cytokines > IL-15 > H_IL15 Reporter Cell Line
classify
H_IL15 Reporter Cell Line
Description
Cat. No: GM-C25386
Product: H_IL15 Reporter Cell Line


Interleukin-15 (IL-15) is a pro-inflammatory protein that plays a role in the activation of neutrophils, dendritic cells, and macrophages. It is essential for the development and survival of NK cells and CD8+ T cells.

IL-15 binds to the IL-15Rα receptor and is subsequently presented to surrounding cells with the IL-15Rβγ complex on their surface. It then binds to the IL-15Rβ and IL-15Rγ(common gamma chain, γc) dimer, forming a heterotrimeric receptor complex. IL-15 triggers the phosphorylation of the JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway, after which the phosphorylated STATs dimerize or tetramerize and translocate into the nucleus.

H_IL15 Reporter Cell Line is a clonal, stable cell line that constitutively overexpresses IL-15Rβ and endogenously expresses the γc, along with signal-dependent expression of a luciferase reporter gene. The addition of IL15 ligand protein agonists stimulates IL15 to bind IL-15Rα, IL-15Rβ/γc, activating downstream reporter genes and inducing luciferase expression. This system can be used to evaluate the in vitro effects of drugs related to IL15.
Data
Response to Human IL-15 protein. H_IL15 Reporter Cell Line (Cat. GM-C25386) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-15 Protein (SinoBiological/10360-H07E) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 16 hours. The firefly luciferase activity was measured using the ONE-GloTM Luciferase Assay System (Promega/E6120). The maximum induction fold was approximately [10.3]. Data are shown by drug mass concentration.
The passage stability of response to Human IL-15 protein. The passage 5, 15 and 25 of H_IL15 Reporter Cell Line (Cat. GM-C25386) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-15(SinoBiological/10360-H07E) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Specifications
Cat. NoGM-C25386
ProductH_IL15 Reporter Cell Line
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF
Growth mediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Recombinant Human GM-CSFNovoprotein/C003
PuromycinGenomeditech/GM-040401
BlasticidinGenomeditech/GM-040404
Recombinant Human IL-15Sino Biological/10360-H07E
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
ONE-GloTM Luciferase Assay SystemPromega/E6120
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend the cell pellet using the recommended complete medium and adjust the viable cell density to 4-6E5 cells/mL. Then dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 3E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin

Approximately 48 - 72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics.

a)          This cell is a human erythroid leukemia cell, lymphoblast, growing in suspension.

b)         In the suspension, they appear as large, single, round cells. Cells shed a large accumulation of cytoplasmic granules in the culture, which should not be confused with bacteria!

c)          When the cell density reaches 1-1.2E6 cells/mL, perform a 1:2 to 1:3 split, ensuring subculturing every other day. It is essential to perform a full-volume centrifugation and medium replacement during passaging. Do not let the density exceed 1.2E6 cells/mL. It is recommended to use T-25 flasks for subculturing, and you can control the cell density for subculturing by counting.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 6E5 viable cells/mL.

Medium Renewal: Every other day

Notes

a)          To minimize the presence of cytoplasmic granules, it is essential to passage the cells every other day when the cell density reaches 1-1.2E6 cells/mL. During passaging, perform a complete centrifugation and replace the culture medium to ensure appropriate cell density and cytokine concentration. Failure to do so may promote the growth of factor-independent subclones.

 

Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit